Skip to main content

ABB Optical Group Introduces VisibleBliss™ Phoropter Mask Personal Protection Equipment Solution

- Single-use barrier attaches to the phoropter and is designed to contour to the patient’s face to trap contaminants and prevent lens fogging for greater protection, improved exam accuracy and peace of mind -

Coral Springs, Fla. (September 14, 2020) – ABB Optical Group (ABB), a leading provider of optical products and business solutions in the eye care industry, announced today that it will be exclusively launching the VisibleBliss™ personal protective equipment (PPE) solution to the eye care industry, in conjunction with VisibleBliss LLC.

Designed by an eye care professional for use in eye care practices, the new VisibleBliss™ phoropter mask is a solution for many eye care practices. Each single-use, recyclable mask attaches directly to the phoropter to help protect doctors and their patients. The patent-pending product is designed to trap contaminants and prevent fogging of the phoropter lenses during refraction.

“ABB continues to listen to the needs of ECPs across the country, so that we can assist in providing them with products, services and solutions to support their success in an ever-changing, evolving environment,” said ABB Optical Group Senior Vice President of Strategy and Commercialization Erika Jurrens. “Giving ECPs the ability to implement additional health and safety measures through the use of a protective phoropter mask such as VisibleBliss™ aligns with our goal of ensuring that ECPs can successfully continue to provide essential healthcare of the best quality to each and every patient.”

In a recent survey, three out of every four ECPs who tested the VisibleBliss™ phoropter mask agreed that it provided an added level of protection against contaminants and provided peace of mind for both staff and patients during eye exams. More than 85 percent found the process of setting up, attaching and changing out the masks to be easy, and more than two thirds of pilot users found the phoropter masks to be effective in preventing or reducing fogging of phoropter lenses as typically caused by patients wearing PPE (e.g., face or cloth masks).

“Unexpected patient sneezes and coughs are virtually impossible to avoid. I designed the VisibleBliss™ phoropter mask to trap these contaminants and reduce lens fogging, which allows ECPs to focus on providing the highest quality of eye care,” said Dr. Elvin Fenton, creator of the VisibleBliss™ phoropter mask. “While improving patient care is our top priority, ECPs have reported significant improvement in chair time due to reduced need for equipment cleaning, which will deliver practice benefits long after we all move past this pandemic.”

ABB customers can order the VisibleBliss™ phoropter mask through their ABB account. Currently, the product is designed to be compatible with manual phoropters, but additional designs are planned for automatic models early in 2021. For more information, visit For more information on ABB Optical Group’s full suite of business solutions that can be tailored to individual eye care practices, visit

About ABB Optical Group
ABB Optical Group is a leading provider of optical products, services and business solutions in the eye care industry. ABB operates through three business pillars: ABB Contact Lens, ABB Labs and ABB Business Solutions. ABB is focused on the future of eye care professionals, helping them succeed by making practices more efficient and assisting providers to effectively navigate market changes. Visit for more information.

The VisibleBliss Phoropter Mask is has not been FDA cleared or approved. The product has been authorized by FDA under an EUA for use as source control by the general public as well as by Health Care Practitioners in healthcare settings as to help prevent the spread of infection or illness during the COVID-19 pandemic. This product is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of medical devices, including alternative products used as medical devices, during the COVID-19 outbreak, under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1) unless the authorization is terminated or revoked sooner. For further information, please visit

Media Contacts:
Cristina Pasquino, 561-271-7240

Other News

Set Proper Expectations for Better Patient Relationships and Retention
Spring 2021 Newsletter

Set Proper Expectations for Better Patient Relationships and Retention

Setting proper expectations for patients can be as important as fitting them with the proper contact lens.

Five Steps to Building Contact Lens Referrals to Your Practice
Spring 2021 Newsletter

Five Steps to Building Contact Lens Referrals to Your Practice

Have you built expertise in specialty contact lenses? Or are you just starting to do so? Learn how to gain outside referrals.

Increasing Practice Value and Revenue with Technology
Spring 2021 Newsletter

Increasing Practice Value and Revenue with Technology

Patient satisfaction is an all-encompassing measurement that pertains to the entire patient experience.

Sign Up for Our Newsletter

Stay up to date on the latest news, trends and technologies that are transforming the eye care industry. As a partner in your practice’s performance – our goal is to make sure you have the information you need to succeed.

Sign up for our newsletter